Kaleido Biosciences, Inc. (NASDAQ:KLDO) Receives Consensus Rating of “Buy” from…
Kaleido Biosciences, Inc. (NASDAQ:KLDO) has been given an average rating of "Buy" by the six ratings firms that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation,…